Reference schedules

Retatrutide and Tirzepatide titration schedules

These tables summarise the step-up patterns used in published research protocols for each compound. They are provided as laboratory reference material only — nothing here is a recommendation for human use.

Retatrutide 20mg pen

£220 + postage
StageWeekly amountNotes
Weeks 1–42 mgIntroductory phase — lowest research increment
Weeks 5–84 mgFirst step up, only if week 4 was well tolerated
Weeks 9–126 mgMid-range research window
Weeks 13–168 mgUpper-mid range, hold longer before stepping again
Weeks 17+10–12 mgTop of the studied range in Phase 2 protocols

Tirzepatide pen

£185 + postage
StageWeekly amountNotes
Weeks 1–42.5 mgStarting increment used across trial protocols
Weeks 5–85 mgFirst maintenance level
Weeks 9–127.5 mgStep up only after four steady weeks
Weeks 13–1610 mgCommon upper maintenance level
Weeks 17+12.5–15 mgMaximum studied range

Reading the pen dial

Pens are dialled in units, not milligrams. Divide the cartridge strength by its volume to get the concentration, then work out the units for the amount you need.

CartridgeConcentration2 mg equalsDoses per cartridge
20 mg in 2 ml10 mg / ml0.2 ml (20 units)10 × 2 mg steps
10 mg in 1 ml10 mg / ml0.2 ml (20 units)5 × 2 mg steps

Schedule handling notes

  • → One administration per week, same day each week where possible
  • → Hold each step for a full four weeks before stepping up
  • → Step back down a level rather than skipping a week if tolerance drops
  • → Bring the pen to room temperature and prime before every use
  • → Fresh needle each time; rotate sites; sharps bin for disposal
  • → Return the pen to 2–8°C storage between sessions
Need the printed version? The 20mg pen guide (PDF) covers the same schedule alongside specs, pathways and storage.

Supplied strictly for laboratory research purposes. Not for human or veterinary consumption. No information on this page is medical advice.

Order in minutes

Free postage on 2+ pens · replies in hours

WhatsApp order